Skip to main content
. 2020 Feb 20;88(3):e00779-19. doi: 10.1128/IAI.00779-19

TABLE 1.

Baseline characteristics of HIV-infected participants with cryptococcal meningitis or noncryptococcal meningitis and healthy control subjectsa

Group Cryptococcal meningitis
Noncryptococcal meningitis
Healthy controls
P value
No. Median (IQR) or no. (%) No. Median (IQR) or no. (%) No. Median (IQR) or no. (%)
Total no. 31 12 10
Clinical parameters
    Age (yr) 31 38 (32–41) 12 39 (35–45) 8 39 (36.5–46.5) 0.81
    Female gender 31 8 (25.8) 12 6 (50) 8 4 (50.0) 0.13
    Weight (kg) 15 54 (50–58.0) 3 60 (51.0–74.0) 0.31
    CD4+ T cells/μl (normal, 800 to 1,200) 22 13.5 (6–46.3) 7 53.0 (7.0–279.0) 0.3
    Currently on ART 31 2 (6.5) 12 0 (0.0)
    Currently receiving TB therapy 31 1 (3.2) 12 1 (8.3) 0.48
    Glasgow coma score of <15 30 7 (23.3) 12 7 (58.3) 0.03
CSF parameters
    Quantitative cryptococcal CFU/ml (log10) 30 4.6 (4.1–5.3) 12 0 (0–0)
    Sterile cryptococcal cultures 30 1 (3.3) 12 12 (100.0)
    Opening pressure (mm/H2O) 25 259 (160–370) 11 230 (128–278) 0.32
    Opening pressure of >250 mm/H2O 25 12 (48.0) 11 3 (27.3) 0.25
    Total WBC counts (cells/μl) 28 17.5 (4.0–112.5) 11 65 (4.0–320.0) 0.45
    Total WBC counts of >5 (cells/μl) 28 15 (53.6) 11 7 (63.6) 0.57
    CSF protein (mg/dl) 30 59 (20.0–97.0) 12 95.5 (43–187.0) 0.16
a

Statistics used to generate the tabulated values were as follows: chi-square test for comparing proportions between groups, and Kruskal-Wallis test for comparing medians among groups. TB, tuberculosis; WBC, white blood cells; IQR, interquartile range.